title: Ten days vs. 14 days antibiotic therapy in culture-proven neonatal sepsis.
abstract: BACKGROUND
  There are no evidence-based guidelines for the treatment of neonatal sepsis although standard text books recommend 14 days of antibiotics for blood culture-proven neonatal sepsis.
  
  
  OBJECTIVE
  The present study compared the effectiveness of a 10-day course of antibiotic therapy with the conventional 14-day course in blood culture-proven neonatal sepsis.
  
  
  METHODS
  Infants ≥ 32 weeks and ≥ 1.5 kg weight with blood culture-proven sepsis were randomized to either 10-day (study group) or 14-day (control group) therapy on Day 7 of appropriate antibiotic therapy, if they were in clinical remission and were C-Reactive Protein (CRP) negative. The primary outcome was treatment failure within 28 days defined by either positive CRP or positive blood culture or clinical relapse.
  
  
  RESULTS
  The baseline characteristics were comparable between the two groups. There was one treatment failure in each group. The duration of hospital stay was significantly shorter in the 10-day treatment group.
  
  
  CONCLUSIONS
  Ten-day antibiotic therapy is as effective as 14-day therapy in blood culture-proven neonatal sepsis, if the infant has achieved clinical remission by Day 7 of therapy.
authors.affiliation: Division of Neonatology, Department of Pediatrics, Pt.B.D.Sharma PGIMS, Rohtak, Haryana, India. geetagathwala09@gmail.com
authors.forename: Geeta
authors.initials: G
authors.lastname: Gathwala
authors.forename: Arvind
authors.initials: A
authors.lastname: Sindwani
authors.forename: Jagjit
authors.initials: J
authors.lastname: Singh
authors.forename: Ojasvini
authors.initials: O
authors.lastname: Choudhry
authors.forename: Uma
authors.initials: U
authors.lastname: Chaudhary
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002097:C-Reactive Protein / Q000378:metabolism; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D018805:Sepsis / Q000097:blood / Q000188:drug therapy*; D013262:Stevens-Johnson Syndrome / Q000097:blood / Q000188:drug therapy; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002097:C-Reactive Protein